Results 181 to 190 of about 3,067,250 (321)
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir +12 more
wiley +1 more source
A Degree Sequence Version of the Kühn–Osthus Tiling Theorem [PDF]
Joseph Hyde, Andrew Treglown
openalex +1 more source
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Forensic utilization of NGS-STRs and evaluation of system efficacy for different kinship identifications. [PDF]
Xu H +9 more
europepmc +1 more source
Parallel Algorithm for Generating Massive Random Networks with a Given Sequence of Expected Degrees. [PDF]
Md. Mahmudul Alam, Maleq Khan
openalex
Asymptotic enumeration of orientations of a graph as a function of the\n out-degree sequence [PDF]
Mikhail Isaev +2 more
openalex +1 more source
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
On majorization of closed walks vector of trees with given degree sequences [PDF]
Yahong Chen +3 more
openalex +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
Representative Random Sampling of Chemical Space. [PDF]
Monterrubio-Chanca DJ, von Rudorff GF.
europepmc +1 more source

